DI VIRGILIO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 24.761
EU - Europa 7.482
AS - Asia 4.849
OC - Oceania 42
SA - Sud America 42
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 10
Totale 37.202
Nazione #
US - Stati Uniti d'America 24.680
CN - Cina 2.415
DE - Germania 2.032
UA - Ucraina 1.575
IT - Italia 1.455
SG - Singapore 1.094
TR - Turchia 985
GB - Regno Unito 704
FI - Finlandia 406
SE - Svezia 358
RU - Federazione Russa 340
PL - Polonia 242
ID - Indonesia 148
FR - Francia 90
BE - Belgio 79
CA - Canada 74
VN - Vietnam 57
HK - Hong Kong 48
AU - Australia 36
CZ - Repubblica Ceca 28
BR - Brasile 27
LT - Lituania 26
RO - Romania 24
IE - Irlanda 20
IR - Iran 20
IN - India 19
JP - Giappone 19
NL - Olanda 19
CH - Svizzera 18
ES - Italia 17
DK - Danimarca 11
EU - Europa 11
KR - Corea 9
IL - Israele 8
GR - Grecia 7
MX - Messico 7
IQ - Iraq 6
NZ - Nuova Zelanda 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BD - Bangladesh 5
EG - Egitto 5
AR - Argentina 4
AT - Austria 4
BG - Bulgaria 4
EC - Ecuador 4
LU - Lussemburgo 4
MD - Moldavia 4
AM - Armenia 3
CO - Colombia 3
EE - Estonia 3
HR - Croazia 3
PT - Portogallo 3
TW - Taiwan 3
CL - Cile 2
DZ - Algeria 2
SA - Arabia Saudita 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
LI - Liechtenstein 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 37.202
Città #
Fairfield 3.221
Woodbridge 3.031
Houston 2.106
Jacksonville 1.824
Chandler 1.735
Ann Arbor 1.603
Ashburn 1.433
Wilmington 1.201
Seattle 1.150
Cambridge 941
Singapore 844
Santa Clara 839
Izmir 684
Nanjing 532
Ferrara 513
Princeton 441
Beijing 369
Boardman 300
San Diego 289
Warsaw 225
Addison 209
Shanghai 203
Nanchang 150
Jakarta 147
New York 147
Shenyang 146
Milan 145
Dearborn 134
Bremen 115
Hebei 107
Los Angeles 107
Tianjin 99
Jiaxing 96
Redwood City 86
Brussels 76
Changsha 76
Munich 71
London 69
Mountain View 68
Norwalk 67
Helsinki 59
Falls Church 57
Dong Ket 56
Zhengzhou 55
Jinan 52
San Mateo 48
Kunming 42
Ningbo 41
Guangzhou 39
Rome 38
Hong Kong 36
Orange 35
Auburn Hills 32
Des Moines 30
Indiana 30
Toronto 29
Chicago 28
Tappahannock 27
Augusta 26
Bologna 26
Washington 26
Frankfurt am Main 25
Ottawa 24
Taizhou 24
Hangzhou 23
Padova 23
Verona 22
Catania 21
Brno 20
Philadelphia 20
Redmond 18
Lanzhou 16
Monmouth Junction 16
Haikou 15
Kilburn 13
Lappeenranta 13
Leawood 13
Rovereto 12
San Francisco 11
Montréal 10
Changchun 9
Copenhagen 9
Ferrara di Monte Baldo 9
Palermo 9
Ardabil 8
Hefei 8
Napoli 8
Pescara 8
Walnut 8
Chengdu 7
Dublin 7
Falkenstein 7
Fuzhou 7
Hounslow 7
Trento 7
Vicenza 7
Acton 6
Berkeley 6
Calvisano 6
Chiswick 6
Totale 26.899
Nome #
P2X7 receptor involvement in the pathogenesis of Hidradenitis Suppurativa 320
I recettori purinergici P2 e le ectonucleotidasi: nuovi bersagli per lo sviluppo di farmaci anti-tumorali/P2 purinergic receptors and ectonucleotidases: novel targets for anti-cancer drugs (FIRB Accordi di programma n. RBAP11FXBC) 250
IL PROCESSO INFIAMMATORIO 203
Il recettore purinergico P2X7 come modulatore della fisiologia mitocondriale e del processo apoptotico 203
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7 184
P2X7 targeting inhibits growth of human mesothelioma 178
Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells. 172
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 170
1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: Correlation with histological variants and clinical parameters 163
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 163
Amyloid beta-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine 161
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 154
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 153
p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner 153
Silencing of P2X7 receptor reduces B16 melanoma growth both in vitro and in vivo 151
Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP 151
A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion 149
ATP release from chemotherapy-treated dying leukemia cells Elicits an immune suppressive effect by increasing regulatory T cells and Tolerogenic dendritic cells 147
Purinergic signaling in the immune system 146
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 145
P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration 144
Role of P2X7 receptor in host response to melanoma 144
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination 140
Expression of P2X7 receptor increases in vivo tumor growth 138
Extracellular purines, purinergic receptors and tumor growth 138
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration 137
Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis 137
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment 137
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes 137
The antibiotic polymyxin B modulates P2X7 receptor function 136
The P2X7 receptor is a key modulator of aerobic glycolysis. 136
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 134
Increased level of extracellular ATP at tumor sites: In vivo imaging with plasma membrane luciferase 133
Stimulation of Purinergic Receptors Modulates Chemokine Expression in Human Keratinocytes 133
The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein 132
The P2X7 receptor-interleukin-1 liaison 132
Functional and structural alterations in the endoplasmic reticulum and mitochondria during apoptosis triggered by C2-ceramide and CD95/APO-1/FAS receptor stimulation 131
The P2X7 receptor: a key player in IL-1 processing and release 131
The antibiotic polymyxin B modulates P2X7 receptor function 131
Purinoceptor function in the immune system 129
Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation 129
Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors 128
Increased sensitivity of DMD lymphoblastoid cell to low doses of X irradiation 127
ATP-mediated cytotoxicity in microglial cells 127
P2 receptors in cancer progression and metastatic spreading 127
Activation of human eosinophils via P2 receptors: novel findings and future perspectives 126
Calcium and inositolphosphates in the activation of T cell-mediated cytotoxicity 126
Insight on P2X7 receptor role as oncogene 125
Extracellular nucleotides and nucleosides as signalling molecules 125
The P2X7 Receptor in Infection and Inflammation 124
ATP secreted by endothelial cells blocks CX 3CL1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y 11 receptor activation 123
La stimolazione del recettore P2X7 causa il rilascio di microvescicole contenenti IL-1 beta da parte di cellule dendritiche umane 122
The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels 121
Purinergic regulation of airway inflammation 120
Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma 120
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4 120
Activation of muscarinic receptors in PC12 cells. Correlation between cytosolic Ca2+ rise and phosphoinositide hydrolysis. 119
Acute myeloid leukaemia:analysis of the expression of P2X7a and P2X7B isoforms 119
Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients 118
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 118
The human cathelicidin LL-37 modulates the activities of the P2X 7 receptor in a structure-dependent manner 118
Idiopatic inflammatory myopathies: serological and clinical correlations. Analysis of a monocentric series 117
Role of the P2X7 receptor in tumor-associated inflammation 117
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance 117
5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes 116
ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment. 116
Non-nucleotide agonists triggering P2X7 receptor activation and pore formation 116
Intracellular signalling in Te85 osteosarcoma cells expressing P2X7R isoforms A and B 115
The P2X7 receptor : from ion channel to oncogene 115
Dysfunctional inflammasome in Schnitzler's syndrome 115
null 115
P2X7A and B as novel biomarkers of acute myeloid leukemia response to chemotherapy and innovative therapeutic targets for the disease 115
Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. 113
Activation of muscarinic receptors in PC12 cells. Stimulation of Ca2+ influx and redistribution. 113
Sidedness of e− Donation and Stoichiometry of H+ Pumps at Sites II + III in Mitochondria from Rat Liver 113
P2 purinoceptors in the immune system 113
The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease 113
Plasma P2X7 receptor correlation with plasma C-reactive protein in infectious diseases 113
Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells 112
Synthesis, biological activity and molecular modeling studies of 1,2,3,4-tetrahydroisoquinoline derivatives as conformationally constrained analogues of KN62, a potent antagonist of the P2X(7)-receptor containing a tyrosine moiety 111
null 111
null 111
Cell-mediated cytotoxicity: ATP as an effector and the role of target cells 111
Purinergic P2Y(2) Receptors Promote Neutrophil Infiltration and Hepatocyte Death in Mice With Acute Liver Injury 111
Inhibitory effect of P2X7 receptor antagonists on in vivo tumor growth 111
The P2X7 receptor and pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF 111
An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes 111
Acute retinal ganglion cell injury caused by intraocular pressure spikes is mediated by endogenous extracellular ATP. 110
Structure-activity relationships around the KN-62, a potent antagonist of the P2X(7)receptor 110
Fc receptor-mediated phagocytosis occurs in macrophages at exceedingly low cytosolic Ca2+ levels. 110
ATP receptors and giant cell formation 110
Liaisons dangereuses: P2X7 and the inflammasome 109
The Serotoninergic Receptors of Human Dendritic Cells: Identification and Coupling to Cytokine Release 109
P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production 109
H+/site, charge/site, and ATP/site ratios in mitochondrial electron transport. 109
Characterization of P2X7 isoform B sheds light on the role of pore versus channel activity in P2X7 mediated life and death. 108
Role of the purinergic P2Z receptor in spontaneous cell death in j774 macrophage cultures 108
Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes 108
Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells 108
Increased sensitivity to extracellular ATP of fibroblasts from patients affected by systemic sclerosis 108
Totale 13.176
Categoria #
all - tutte 175.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.085
Totale 179.573


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.605 0 0 0 0 503 907 653 776 612 673 311 170
2020/20215.249 457 432 230 571 286 530 223 597 202 659 703 359
2021/20224.501 123 468 260 157 278 213 237 250 197 356 434 1.528
2022/20234.150 486 173 139 487 685 598 123 447 540 53 280 139
2023/20242.128 235 314 91 62 189 262 91 145 47 49 93 550
2024/20252.681 266 276 718 359 1.062 0 0 0 0 0 0 0
Totale 37.879